A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2004
10/21/2004	DE102004010690A1 Gesundheitsfördernde Zusammensetzungen aus lipidhaltigen Pilzen und Thiocyanaten Health-promoting compositions of lipid-containing mushrooms and thiocyanates
10/21/2004	CA2707750A1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol
10/21/2004	CA2523186A1 Method of screening drug with the use of 67 kda laminin receptor and drug obtained thereby
10/21/2004	CA2521713A1 Anti-fungal peptidomimetics
10/21/2004	CA2521632A1 Pharmaceutical combination containing tamsulosin and a non-steroidal anti-inflammatory drug
10/21/2004	CA2521429A1 Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care
10/21/2004	CA2520865A1 Zwitterionic immunomodulators for the treatment of asthma and allergy
10/21/2004	CA2519380A1 Compositions and method for treating microbial and parasitic infections in cattle and other animals
10/21/2004	CA2519379A1 Method of treating lower urinary tract disorders
10/20/2004	EP1469316A1 Screening method
10/20/2004	EP1469308A1 Method of screening drug
10/20/2004	EP1469084A2 Polymorphisms in the human KDR gene
10/20/2004	EP1468698A2 Human quinone reductase 2 conjugates for adept and gdept
10/20/2004	EP1468696A1 Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases
10/20/2004	EP1468695A1 Methods and compositions useful for inhibition of angiogenesis
10/20/2004	EP1468118A2 Methods and compositions for treating cancer
10/20/2004	EP1468110A2 Molecular signatures of commonly fatal carcinomas
10/20/2004	EP1468098A2 Method of inhibiting pathogenicity of infectious agents
10/20/2004	EP1468097A2 METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM V sb H /sb AND V sb L /sb DOMAINS
10/20/2004	EP1468091A2 Transmembrane protein
10/20/2004	EP1468078A1 Method and device for identifying substances capable of modulating adipocyte differentiation
10/20/2004	EP1468019A2 Secreted protein
10/20/2004	EP1468018A2 Leptin proteins
10/20/2004	EP1468017A1 A complex of a human foxc2 protein and a foxc2-interacting protein
10/20/2004	EP1468008A2 MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) PROMOTER POLYMORPHISM IN INFLAMMATORY DISEASE
10/20/2004	EP1467998A1 Tetracyclic heterocompounds as estrogen receptor modulators
10/20/2004	EP1467979A2 FUSED HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF&colon; MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION
10/20/2004	EP1467972A1 Indazole compounds useful as protein kinase inhibitors
10/20/2004	EP1467970A1 Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
10/20/2004	EP1467965A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
10/20/2004	EP1467768A1 Increasing electro-gene transfer of nucleic acid molecules into host tissue
10/20/2004	EP1467765A2 Combination therapy for the treatment of bacterial infections
10/20/2004	EP1467764A1 Statins (hmg-coa reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
10/20/2004	EP1467763A1 Methods for treatment of multiple sclerosis with statins
10/20/2004	EP1467762A1 Use of an h1 antagonist and a safe steroid to treat rhinitis
10/20/2004	EP1467760A2 Systems and methods for photodynamic therapy
10/20/2004	EP1467759A2 Compositions and methods related to tim-3, a th1-specific cell surface molecule
10/20/2004	EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS
10/20/2004	EP1467743A1 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
10/20/2004	EP1467742A1 Use of alkylphosphocholines for the preventative treatment of protozoan diseases
10/20/2004	EP1467741A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies
10/20/2004	EP1467740A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases
10/20/2004	EP1467739A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators
10/20/2004	EP1467736A2 Anti-angiogenesis combination therapies comprising pyridazine or pyridine derivatives
10/20/2004	EP1467734A1 Cotherapy with an oxazolidinone and a vitamin b
10/20/2004	EP1467728A1 Pharmaceutical compositions comprising valsartan and nep inhibitors
10/20/2004	EP1467716A2 Polytartrate composition
10/20/2004	EP1467714A1 Drug mixture with enhanced dissolution rate
10/20/2004	EP1467712A1 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic
10/20/2004	EP1467707A1 Composition for easing human childbirth
10/20/2004	EP1467705A2 Therapeutic agent delivery tampon
10/20/2004	EP1467695A2 Hiv integrase inhibitors
10/20/2004	EP1404180A4 Peripheral blood fibrocytes differentiation pathway and migration to wound sites
10/20/2004	EP1309503B1 Medical spray device
10/20/2004	EP1307264B1 New pharmaceutical composition
10/20/2004	EP1289936B1 Substituted stilbenes as glucose uptake enhancers
10/20/2004	EP1206276B1 Tissue volume reduction
10/20/2004	EP1198477B1 Prolactin-releasing peptide and use in treating pain
10/20/2004	EP1071667A4 Receptor ligands
10/20/2004	EP0831860B1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
10/20/2004	CN1539014A Templated molecules and methods for using such molecules
10/20/2004	CN1538853A T cell regulatory genes and methods of use thereof
10/20/2004	CN1538840A Perfume compositions
10/20/2004	CN1538837A Swallow tablet comprising paracetamol
10/20/2004	CN1538835A Ophthalmic depot fomulations for periocular or conjunctival administration
10/20/2004	CN1538825A Biodegradable injectable implants and related method of manufacture and use
10/20/2004	CN1538812A Body temp-raising agent of amino acidds for eating or drinking and for medical use
10/20/2004	CN1538809A Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, used thereof and methods of making same
10/20/2004	CN1537637A Nucleic acid vaccine
10/20/2004	CN1537634A Medicine contg. biotin for treating diabetes
10/20/2004	CN1171997C Modified TLE-2-receptor ligands
10/20/2004	CN1171874C Combinations of protein farnesyltransferase and HMG COA reductase inhibitors and their use to treat cancer
10/20/2004	CN1171637C Vaccine against nepatitis B Birus and human papilloma virus
10/20/2004	CN1171586C Pharmaceutical compositions comprising monoamine oxidase B inhibitors
10/20/2004	CN1171579C Foaming compsn. for hair care
10/19/2004	US6806261 Control release transforming growth factor; central nervous system disorders; antiproliferative agent
10/19/2004	US6806257 Using such as oroxylin a and/or wogonin; septic shock, aneurysm, angiotensin converting enzyme inhibition; antiinflammatories
10/19/2004	US6806253 Therapeutic and preventive anti-bacterial vaccine complex
10/19/2004	US6806059 Nucleotide sequences coding enzymatic polypeptide for use innthe treatment of asthma, and for use in laundry detergent and stain removers
10/19/2004	US6805875 A mixture consisting of sodium hydrogen carbonate, magnesium hydroxide, calcium carbonate, and aluminum hydroxide, anhydrous base ointment, polysorbate 80, butylated hydroxy toluene; topical applying
10/19/2004	US6805863 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
10/19/2004	US6805854 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route
10/19/2004	CA2323096C Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
10/14/2004	WO2004087740A2 Preserved and stable compositions containing peptide copper complexes and methods related thereto
10/14/2004	WO2004087212A2 Nitric oxide in treatment of inflammation
10/14/2004	WO2004087211A2 Inhibitors of phosphodiesterases in infertility
10/14/2004	WO2004087209A1 Preparation for sustaining therapeutically effective blood concentration of analgesic activity potentiator
10/14/2004	WO2004087198A1 Use of coagulation proteins to lyse clots
10/14/2004	WO2004087176A1 A composition (rucd) for protecting and/or repairing dna from oxidative damages and a method thereof
10/14/2004	WO2004087171A1 Methods for treating arthritic conditions
10/14/2004	WO2004087169A1 Antiviral combination of nevirapine and a further antiretroviral compound
10/14/2004	WO2004087167A2 Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
10/14/2004	WO2004087161A1 Combinations comprising anti-epileptic drugs for the treatment of neurological disorders
10/14/2004	WO2004087160A1 Treatment of neurological conditions
10/14/2004	WO2004087152A1 Dosage forms comprising ag013736
10/14/2004	WO2004087151A1 Medicinal composition
10/14/2004	WO2004087150A1 Drug composition
10/14/2004	WO2004087140A1 Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound
10/14/2004	WO2004087139A1 Antiviral combination of tipranavir and a further antiretroviral compound
10/14/2004	WO2004087130A1 Hepatoprotective pharmaceutical composition comprising a mixture of coumarinolignoids and process for preparation thereof

1 ... 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 ... 1151